Nov 7 (Reuters)-
Cosmo Bio Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2024 Sep 30, 2023 Dec 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 7.41 6.88 9.80
(+7.7 pct) (-3.5 pct) (+4.9 pct)
Operating 369 mln 447 mln 390 mln
(-17.5 pct) (-36.4 pct) (-25.0 pct)
Recurring 384 mln 554 mln 450 mln
(-30.6 pct) (-19.6 pct) (-31.1 pct)
Net 291 mln 366 mln 310 mln
(-20.4 pct) (-19.4 pct) (-30.0 pct)
EPS 49.92 yen 62.84 yen 53.12 yen
Ann Div 30.00 yen 50.00 yen
-Q2 div 14.00 yen 14.00 yen
-Q4 div 16.00 yen 36.00 yen
NOTE - Cosmo Bio Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T